A rare coronary anomaly: origin of the right coronary artery from the left ventricular outflow tract.

of Oxford, Xoma; Research grants from Amgen, Celladon, Novartis, Sanofi-Aventis; Co-inventor of patents for the use of inhibitors of the renin–angiotensin system in selected survivors of MI with Novartis Pharmaceuticals AG and Boehringer Ingelheim, GMBH. Dr Pfeffer’s share of the licensing agreements is irrevocably transferred to charity. W.G.S.: Consulting:Menarini Farmaceutica Internazionale S. R. L. A. B.M.P.: Advisory board/steering committee, Bayer Healthcare, Servier, Novartis, Menarini.